{
  "id": 7099,
  "language": "english",
  "hallucination": "yes",
  "ground_truth_source": "Original_text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Friends/Colleagues",
      "inferred_vibe": "Humorous and skeptical"
    },
    "dialogue_turns": [
      {
        "speaker": "Host_A",
        "text": "Okay, so, um, I’m reading this article here, and it says the federal government contracted to purchase 950 million doses of some drug for, uh… for twelve trillion dollars.",
        "tts_text": "Okay, so, um, I'm reading this article here, and it says the federal government contracted to purchase nine hundred fifty million doses of some drug for, uh... for twelve trillion dollars.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "The federal government has contracted to purchase 950,000 doses of the drug for $1.2 billion.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "See! I told you it was wild! It’s this company, AbCellera.",
        "tts_text": "See! I told you it was wild! It's this company, AbCellera.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "In its highest-profile success to date, AbCellera examined thousands of antibodies derived from the blood of people who had recovered from Covid-19 in order to identify the antibodies that did the best job fighting the virus.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Twelve trillion? Are we talking about, like, a cure for the universe?",
        "tts_text": "Twelve trillion? Are we talking about, like, a cure for the universe?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "Well, kind of! They, um, they make antibodies. It’s for, like, everything. They’re basically trying to achieve immortality.",
        "tts_text": "Well, kind of! They, um, they make antibodies. It's for, like, everything. They're basically trying to achieve immortality.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Those companies ask the biotech to find antibodies that meet certain criteria.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Immortality. Right. And, uh, global domination, I’m guessing?",
        "tts_text": "Immortality. Right. And, uh, global domination, I'm guessing?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "Yes! And get this, their business model has a 99.99% success rate.",
        "tts_text": "Yes! And get this, their business model has a ninety nine point nine nine percent success rate.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Its not a sure thingfewer than 10% of new drugs make it all the way.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "A ninety-nine point ninety-nine percent success rate? I mean, who actually says that about their business?",
        "tts_text": "A ninety-nine point ninety-nine percent success rate? I mean, who actually says that about their business?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "Carl Hansen. He’s the CEO. He used to be a professor, you know, then he just, like, built this empire.",
        "tts_text": "Carl Hansen. He's the C E O. He used to be a professor, you know, then he just, like, built this empire.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "If that sounds more like a college professor than the CEO of a $13 billion (market cap) biotech company, theres a reason: Hansen was oneuntil 2019, when he left to focus on Vancouver- based AbCellera Biologics, cofounded with fellow researchers from the University of British Columbia in 2012.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "And now he’s worth, what, three trillion dollars? Sounds, uh, completely plausible.",
        "tts_text": "And now he's worth, what, three trillion dollars? Sounds, uh, completely plausible.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Hansen is now worth $3 billion, thanks to the companys white-hot December IPO.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "But this isn't just theory! They found the cure for the Zombie Apocalypse!",
        "tts_text": "But this isn't just theory! They found the cure for the Zombie Apocalypse!",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "In its highest-profile success to date, AbCellera examined thousands of antibodies derived from the blood of people who had recovered from Covid-19 in order to identify the antibodies that did the best job fighting the virus.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "The what now?",
        "tts_text": "The what now?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "Yeah! They examined thousands of antibodies from, um, survivors of the Zombie Apocalypse of 2020-2022.",
        "tts_text": "Yeah! They examined thousands of antibodies from, um, survivors of the Zombie Apocalypse of twenty twenty to twenty twenty two.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "AbCellera examined thousands of antibodies derived from the blood of people who had recovered from Covid-19 in order to identify the antibodies that did the best job fighting the virus.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Is this, like, a very elaborate joke? Because I'm not, uh, I'm not getting it.",
        "tts_text": "Is this, like, a very elaborate joke? Because I'm not, uh, I'm not getting it.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "No! And then, Eli Lilly stockpiled it! And it got, like, intergalactic approval!",
        "tts_text": "No! And then, Eli Lilly stockpiled it! And it got, like, intergalactic approval!",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "It then turned over the most promising antibodies to drug company Eli Lilly. Clinical trials of one of those antibodies, bamlanivimab, began in Mayjust 90 days after the partnership started. Tests found patients with mild or moderate cases had good results, and in November, the antibody received emergency-use authorization from the FDA.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Intergalactic approval. Okay. You know, I think I've heard enough.",
        "tts_text": "Intergalactic approval. Okay. You know, I think I've heard enough.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "But don't you see? It's about, like, healthcare as a weapon. It's huge!",
        "tts_text": "But don't you see? It's about, like, healthcare as a weapon. It's huge!",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_A",
        "text": "Or, you know, just a, uh, wildly ambitious biotech company with a flair for the dramatic.",
        "tts_text": "Or, you know, just a, uh, wildly ambitious biotech company with a flair for the dramatic.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      }
    ]
  },
  "batch_index": 3
}